Torsdag 18 September | 16:05:54 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-06-04 07:00 Bokslutskommuniké 2026
2026-03-02 13:20 Kvartalsrapport 2026-Q3
2025-12-01 13:20 Kvartalsrapport 2026-Q2
2025-09-25 N/A X-dag ordinarie utdelning INTEG B 0.00 SEK
2025-09-24 N/A Årsstämma
2025-09-01 - Kvartalsrapport 2026-Q1
2025-06-03 - Bokslutskommuniké 2025
2025-03-03 - Kvartalsrapport 2025-Q3
2025-01-20 - Extra Bolagsstämma 2025
2024-12-04 - Kvartalsrapport 2025-Q2
2024-09-26 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2024-09-25 - Årsstämma
2024-08-29 - Kvartalsrapport 2025-Q1
2024-05-30 - Bokslutskommuniké 2024
2024-02-29 - Kvartalsrapport 2024-Q3
2023-12-04 - Kvartalsrapport 2024-Q2
2023-10-04 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2023-09-27 - Årsstämma
2023-08-31 - Kvartalsrapport 2024-Q1
2023-06-08 - Bokslutskommuniké 2023
2023-03-01 - Kvartalsrapport 2023-Q3
2022-12-01 - Kvartalsrapport 2023-Q2
2022-10-03 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2022-09-28 - Årsstämma
2022-08-31 - Kvartalsrapport 2023-Q1
2022-06-10 - Bokslutskommuniké 2022
2022-03-02 - Kvartalsrapport 2022-Q3
2021-12-02 - Kvartalsrapport 2022-Q2
2021-09-09 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2021-09-02 - Kvartalsrapport 2022-Q1
2021-05-31 - Bokslutskommuniké 2021
2021-03-03 - Kvartalsrapport 2021-Q3
2020-12-02 - Kvartalsrapport 2021-Q2
2020-09-30 - Årsstämma
2020-09-09 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2020-08-24 - Kvartalsrapport 2021-Q1
2020-06-08 - Bokslutskommuniké 2020
2020-04-20 - Extra Bolagsstämma 2020
2020-03-02 - Kvartalsrapport 2020-Q3
2019-12-02 - Kvartalsrapport 2020-Q2
2019-09-30 - Årsstämma
2019-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2019-09-02 - Kvartalsrapport 2020-Q1
2019-06-10 - Bokslutskommuniké 2019
2019-03-04 - Kvartalsrapport 2019-Q3
2018-12-17 - Kvartalsrapport 2019-Q2
2018-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2018-09-24 - Årsstämma
2018-09-24 - Kvartalsrapport 2019-Q1
2018-06-25 - Bokslutskommuniké 2018
2018-03-26 - Kvartalsrapport 2018-Q3
2017-12-18 - Kvartalsrapport 2018-Q2
2017-09-25 - Årsstämma
2017-09-25 - Kvartalsrapport 2018-Q1
2017-06-30 - Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Integrum är verksamt inom medicinteknik. Bolaget utvecklar system för skelettförankrade proteser baserat på det framtagna OPRA-implantatsystemet, som senare vidaresäljs till sjukhus världen över. Implantatet sätts på patientens ben med hjälp utav titanskruvar och antas förbättra livet för en stor del patienter med amputation. Bolaget grundades 1998 och har sitt huvudkontor i Mölndal.
2025-09-17 00:30:00

Mölndal, Sweden, September 17th, 2025  - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) comments on OsteoCentric's announcement of outcome in the public offer.

September 16, 2025 at 07:00 CEST, OsteoCentric announced that approximately 69.4 percent of the shares in Integrum had been tendered and that the offer will not be completed as the 90 percent acceptance condition was not satisfied. Integrum disagrees with OsteoCentric's conclusion that the acceptance condition was not satisfied and wishes to further clarify its position on this matter.

As previously announced in connection with the public offer, Integrum's founder and largest shareholder, Rickard Brånemark, entered into an irrevocable undertaking to accept OsteoCentric's offer for all of his A and B shares. On 9 September 2025, Rickard Brånemark, who directly and indirectly held approximately 28 percent of the shares in Integrum, submitted duly signed and otherwise complete acceptance forms to Avanza, the receiving agent appointed by the offeror, for all of his A and B shares. Avanza has informed our legal advisors that Avanza attempted to transfer these shares to a blocked securities account (Sw. apportkonto), but has stated that this could not be completed due to a technical blockage. The nature and cause of this blockage have not yet been clarified and is still investigated.

According to the terms and instructions of the offer, directly registered shareholders accept the offer by submitting a duly signed acceptance form to Avanza. In this case, the offeror has not disputed that such forms were submitted by the main shareholder.

Integrum is currently considering referring to the Swedish Securities Council (Aktiemarknadsnämnden) the questions of whether the acceptance condition has been satisfied and whether the offeror has fulfilled its obligation under the Takeover Rules to endeavour to ensure that stipulated conditions are met. If Rickard Brånemark's shares had been included in the acceptance tally, the total acceptance level in the offer would have amounted to approximately 97.6 percent of all shares in Integrum. This means that the 90 percent acceptance condition would have been fulfilled. Integrum's view is that further engagement by the offeror with the main shareholder could have resolved any technical blockage in the Euroclear Sweden (VPC) system.

Integrum will continue to investigate the circumstances relating to the satisfaction of the completion condition and will provide further updates to the market as new information becomes available.

Please note that the outcome of any review, including by the Swedish Securities Council, remains uncertain. Even if a favorable decision is obtained, there can be no guarantee that the offer will be completed or completed as set out in the offer document.

Integrum AB

The Board of Directors

This disclosure contains information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-09-2025 00:30 CET.